论文部分内容阅读
富士药品总公司(日本高冈市)公告:引进了英国剑桥大学部血液医学科教授Abraham Karpas所开发的简便、精确的艾滋病鉴定药。该公司获得了在全世界的销售权,开始进行艾滋病鉴定药的国际性开发。这次引入的艾滋病鉴定药是一种酶免疫测定(EIA)药物。把艾滋病病毒(英国分离的菌株)感染的细胞在标本上固定,与患者的血清反应后,使用一种与过氧化物酶化学结合的试剂(它与同抗体有亲和性的蛋白即蛋白质A发生显色反应),即可查出包含在艾滋病患者血液中的对艾滋病毒的抗体。一次检查所需血清仅10微升;约2小时即可完成鉴定;而且用
Fuji Pharmaceuticals Corporation (Takaoka, Japan) Notice: The introduction of a simple and accurate HIV / AIDS drug developed by Abraham Karpas, a professor of hematology and medicine at the University of Cambridge in the United Kingdom. The company has acquired worldwide sales rights and started international development of HIV medicines. The AIDS drug introduced this time is an enzyme immunoassay (EIA) drug. Cells infected with HIV (a strain isolated in the United Kingdom) are fixed on the specimen and reacted with the patient’s sera using a reagent that chemically associates with the peroxidase, which binds to the protein that has affinity for the antibody, ie, protein A Color reaction occurs), you can detect the AIDS virus contained in the blood of AIDS patients. The serum required for a test is only 10 microliters; identification is completed in about 2 hours; and used